Clinical practice guidelines for PSA testing and early management of test-detected prostate cancer

This guideline provides evidence-based recommendations for PSA testing and immediately consequent clinical care in Australia. Its main purpose is to provide guidance on:

• which testing protocol to recommend to men who decide in favour of testing, depending on their age and underlying risk of prostate cancer
• further investigation of an abnormal PSA test and the early management of prostate cancer diagnosed following such investigation.

The aim of the recommendations, through their application in practice, is to maximise the benefits and minimise the harms of PSA testing in men without symptoms suggestive of prostate cancer.

*Note: If you experience difficulty accessing this guideline please contact us on guidelines@cancer.org.au